An update on the IMProved reduction of outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Califf, RM; Lokhnygina, Y; Cannon, CP; Stepanavage, ME; McCabe, CH; Musliner, TA; Pasternak, RC; Blazing, MA; Giugliano, RP; Harrington, RA; Braunwald, E

Published Date

  • May 2010

Published In

Volume / Issue

  • 159 / 5

Start / End Page

  • 705 - 709

PubMed ID

  • 20435175

Pubmed Central ID

  • 20435175

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2010.03.004

Language

  • eng

Conference Location

  • United States